Charles Schwab Investment Management Inc. Sells 7,234 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Charles Schwab Investment Management Inc. lessened its stake in U.S. Physical Therapy, Inc. (NYSE:USPH - Free Report) by 4.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 141,667 shares of the company's stock after selling 7,234 shares during the period. Charles Schwab Investment Management Inc. owned about 0.94% of U.S. Physical Therapy worth $12,567,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Venturi Wealth Management LLC increased its stake in U.S. Physical Therapy by 3,200.0% in the fourth quarter. Venturi Wealth Management LLC now owns 726 shares of the company's stock valued at $64,000 after purchasing an additional 704 shares in the last quarter. KBC Group NV grew its position in U.S. Physical Therapy by 68.6% in the 3rd quarter. KBC Group NV now owns 774 shares of the company's stock valued at $66,000 after purchasing an additional 315 shares during the period. Pacer Advisors Inc. acquired a new stake in shares of U.S. Physical Therapy in the 4th quarter worth about $113,000. First Horizon Advisors Inc. lifted its position in U.S. Physical Therapy by 25.1% in the 3rd quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company's stock valued at $126,000 after acquiring an additional 298 shares in the last quarter. Finally, Mutual of America Capital Management LLC bought a new stake in U.S. Physical Therapy during the 4th quarter worth approximately $203,000.

Insider Transactions at U.S. Physical Therapy

In other U.S. Physical Therapy news, COO Graham D. Reeve sold 1,730 shares of the business's stock in a transaction that occurred on Friday, March 7th. The stock was sold at an average price of $82.11, for a total value of $142,050.30. Following the completion of the sale, the chief operating officer now owns 7,168 shares in the company, valued at approximately $588,564.48. The trade was a 19.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 1.70% of the company's stock.

Remove Ads

U.S. Physical Therapy Price Performance

NYSE USPH traded down $0.39 on Tuesday, hitting $73.26. The stock had a trading volume of 97,534 shares, compared to its average volume of 99,745. The firm has a 50-day moving average of $84.54 and a 200-day moving average of $86.91. The company has a market capitalization of $1.11 billion, a price-to-earnings ratio of 77.94, a price-to-earnings-growth ratio of 3.54 and a beta of 1.51. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. U.S. Physical Therapy, Inc. has a 52-week low of $72.27 and a 52-week high of $113.63.

U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.65 EPS for the quarter, missing the consensus estimate of $0.69 by ($0.04). U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business had revenue of $180.45 million for the quarter, compared to analysts' expectations of $173.10 million. Equities analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current year.

U.S. Physical Therapy Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 14th will be paid a dividend of $0.45 per share. The ex-dividend date is Friday, March 14th. This is an increase from U.S. Physical Therapy's previous quarterly dividend of $0.44. This represents a $1.80 annualized dividend and a dividend yield of 2.46%. U.S. Physical Therapy's dividend payout ratio (DPR) is 97.83%.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. StockNews.com cut U.S. Physical Therapy from a "hold" rating to a "sell" rating in a research note on Friday, February 28th. JPMorgan Chase & Co. reduced their target price on shares of U.S. Physical Therapy from $120.00 to $110.00 and set an "overweight" rating for the company in a research report on Wednesday, March 19th. Bank of America upgraded U.S. Physical Therapy from a "neutral" rating to a "buy" rating and boosted their target price for the company from $100.00 to $115.00 in a research note on Monday, December 16th. Citizens Jmp upgraded U.S. Physical Therapy to a "strong-buy" rating in a research note on Monday, December 16th. Finally, William Blair reiterated a "market perform" rating on shares of U.S. Physical Therapy in a research report on Thursday, February 27th. One research analyst has rated the stock with a sell rating, one has issued a hold rating, four have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $109.00.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.